Neurocrine Biosciences (NBIX) Tops Q1 EPS by 7c
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $174.26 +3.87%
EPS Growth %: -4.2%
Financial Fact:
Research and development: 20.94M
Today's EPS Names:
CRMT, More
EPS Growth %: -4.2%
Financial Fact:
Research and development: 20.94M
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q1 EPS of ($0.22), $0.07 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $15 million versus the consensus estimate of $15.43 million.
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- Berenberg Starts Brooks Macdonald Group PLC (BRK:LN) at Buy
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
